DVADaVita

$180.08

Is the price fair?

What DVA's price assumes

DaVita trades at 14.8× earnings against 19.7× for the median Medical Care Facilities name, cheaper than its own group.

14.8

Trailing P/E · Medical Care Facilities median 19.7 · cheaper than the typical name in its group

Price / sales
0.77

Price / sales · as of 2026-Q1

Free cash flow yield
12%

Free cash flow yield · Medical Care Facilities median 7.8%

Growth the price implies
−6.2%

Growth the price implies · The price pays for −6.2% free cash flow growth a year for a decade; the business has delivered +5.9% a year over the last three.

Details
Healthcare median P/E362 names
31.5
Medical Care Facilities median P/E29 names
19.7
Free cash flow, trailing twelve months
$1.61B
Market capitalisation
$13.3B
3-year revenue growth
+6.1%
3-year free cash flow growth
+5.9%
What the market has paid for these earnings: 38 quarters of its own multiple × $12.15 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$170.65
Its own P/E history, median$185.96
Its own P/E history, upper quartile$241.02
52-week range$103.87 – $239.50
Today$180.08

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.